Abstract
Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in a Phase 1 Clinical Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have